메뉴 건너뛰기




Volumn 130, Issue 9, 2012, Pages 1226-1227

Reduction of vascular endothelial growth factor A in human breast milk after intravitreal injection of bevacizumab but not ranibizumab

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN A;

EID: 84866058899     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2012.112     Document Type: Article
Times cited : (18)

References (6)
  • 1
    • 47549108068 scopus 로고    scopus 로고
    • Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration
    • DOI 10.1001/archopht.126.7.941
    • Chang LK, Spaide RF, Brue C, Freund KB, Klancnik JM Jr, Slakter JS. Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Arch Ophthalmol. 2008;126(7):941-945. (Pubitemid 352008374)
    • (2008) Archives of Ophthalmology , vol.126 , Issue.7 , pp. 941-945
    • Chang, L.K.1    Spaide, R.F.2    Brue, C.3    Freund, K.B.4    Klancnik Jr., J.M.5    Slakter, J.S.6
  • 2
    • 68249149799 scopus 로고    scopus 로고
    • Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: Preliminary findings of a pilot study
    • Tuebingen Bevacizumab Study Group
    • Ziemssen F, Zhu Q, Peters S, et al Tuebingen Bevacizumab Study Group. Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study. Int Ophthalmol. 2009;29(4):213-224.
    • (2009) Int Ophthalmol , vol.29 , Issue.4 , pp. 213-224
    • Ziemssen, F.1    Zhu, Q.2    Peters, S.3
  • 3
    • 77649253359 scopus 로고    scopus 로고
    • FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye
    • Kim H, Robinson SB, Csaky KG. FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye. Mol Vis. 2009;15:2803-2812.
    • (2009) Mol Vis , vol.15 , pp. 2803-2812
    • Kim, H.1    Robinson, S.B.2    Csaky, K.G.3
  • 4
    • 79955601056 scopus 로고    scopus 로고
    • Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease
    • Chaparro M, Gisbert JP. Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease. Curr Pharm Biotechnol. 2011;12(5):765-773.
    • (2011) Curr Pharm Biotechnol , vol.12 , Issue.5 , pp. 765-773
    • Chaparro, M.1    Gisbert, J.P.2
  • 6
    • 0033744548 scopus 로고    scopus 로고
    • Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine
    • Vuorela P, Andersson S, Carpén O, Ylikorkala O, Halmesmäki E. Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine. Am J Clin Nutr. 2000;72(5):1196-1201.
    • (2000) Am J Clin Nutr , vol.72 , Issue.5 , pp. 1196-1201
    • Vuorela, P.1    Andersson, S.2    Carpén, O.3    Ylikorkala, O.4    Halmesmäki, E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.